Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $140.18 USD
Change Today -0.75 / -0.53%
Volume 55.4K
TARO On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 3:11 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

taro pharmaceutical indus (TARO) Snapshot

Open
$141.08
Previous Close
$140.93
Day High
$141.52
Day Low
$139.23
52 Week High
02/6/15 - $173.00
52 Week Low
05/28/14 - $103.33
Market Cap
6.0B
Average Volume 10 Days
69.4K
EPS TTM
$9.80
Shares Outstanding
42.8M
EX-Date
--
P/E TM
14.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for TARO PHARMACEUTICAL INDUS (TARO)

taro pharmaceutical indus (TARO) Related Businessweek News

No Related Businessweek News Found

taro pharmaceutical indus (TARO) Details

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the United States, Canada, Israel, and internationally. The company offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. The company sells and distributes its products to drug wholesalers and store chains, mass merchandisers, food and retail chains, managed care organizations, generic drug distributors, and others. Taro Pharmaceutical Industries Ltd. was founded in 1959 and is based in Haifa Bay, Israel.

1,342 Employees
Last Reported Date: 07/3/14
Founded in 1959

taro pharmaceutical indus (TARO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

taro pharmaceutical indus (TARO) Key Developments

Taro Pharmaceutical Industries Ltd. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Taro Pharmaceutical Industries Ltd. reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales of $237,700,000 compared to $213,598,000 a year ago. Operating income was $159,320,000 compared to $134,894,000 a year ago. Income before income taxes was $170,914,000 compared to $139,279,000 a year ago. Income from continuing operations was $142,740,000 or $0.33 basic and diluted per share compared to $115,765,000 or $2.59 basic and diluted per share a year ago. Net income attributable to the company was $142,482,000 or $3.33 basic and diluted per ordinary share compared to $115,615,000 or $2.59 per basic and diluted per ordinary share for the same period a year ago. For the nine months, the company reported net sales of $618,764,000 compared to $572,109,000 a year ago. Operating income was $374,090,000 compared to $328,709,000 a year ago. Income before income taxes was $392,176,000 compared to $336,818,000 a year ago. Income from continuing operations was $332,989,000 or $7.76 basic and diluted per share compared to $271,522,000 or $6.05 diluted per share a year ago. Net income attributable to the company was $331,965,000 or $7.75 basic and diluted per ordinary share compared to $270,747,000 or $6.05 per basic and diluted per ordinary share for the same period a year ago. Net cash provided by operating activities was $192,842,000 compared to $273,715,000 a year ago. Purchase of property plant & equipment was $14,019,000 compared to $16,646,000 a year ago.

Taro Pharmaceutical Industries Ltd. to Report Q3, 2015 Results on Feb 10, 2015

Taro Pharmaceutical Industries Ltd. announced that they will report Q3, 2015 results at 5:00 PM, Eastern Standard Time on Feb 10, 2015

Taro Pharmaceutical Industries Ltd., Annual General Meeting, Dec 22, 2014

Taro Pharmaceutical Industries Ltd., Annual General Meeting, Dec 22, 2014., at 10:00 Israel Standard Time. Location: The offices of Meitar Liquornik Geva Leshem Tal. Agenda: To re-elect five directors (Dilip Shanghvi, Subramanian Kalyanasundaram (known in industry circles as Kal Sundaram), Sudhir Valia, James Kedrowski and Dov Pekelman), who are not External Directors (as defined in the Companies Law, to the Company's Board of Directors (the Board of Directors"), to serve until the close of the next annual general meeting, under the same terms of remuneration previously approved by the Company's Audit Committee, Compensation Committee, Board of Directors and Shareholders; To appoint Ziv Haft Certified Public Accountants (Israel), a BDO member firm, as the Company's independent auditors; and to discuss the Company's consolidated financial statements for the year ended March 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TARO:US $140.18 USD -0.75

TARO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $39.70 USD -2.51
Dr Reddy's Laboratories Ltd 3,403 INR +7.60
Glenmark Pharmaceuticals Ltd 897.50 INR -9.10
IGI Laboratories Inc $5.15 USD -0.10
Impax Laboratories Inc $45.67 USD -0.56
View Industry Companies
 

Industry Analysis

TARO

Industry Average

Valuation TARO Industry Range
Price/Earnings 14.9x
Price/Sales 7.5x
Price/Book 4.6x
Price/Cash Flow 14.4x
TEV/Sales 6.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TARO PHARMACEUTICAL INDUS, please visit www.taro.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.